Endo Usa recalls

Endo Usa has 11 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 20 May 2026. 11 are still ongoing. 6 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls11since 2025

Last 12 months6reported

Class I545% of total

Ongoing11latest 20 May 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 4Jan '25 1 0 0Apr 0 0 0Jul 0 0 1Oct 4 0 0Jan '26 0 0 0Apr 1 0 0Jul 0 0

Severity split

Class I 5 45%Class II 1 9%Class III 5 45%

Why endo usa is recalled

Product types

Brands

Clonazepam436%
Buprenorphine Hydrochloride19%

By year

202619%
20251091%

Ongoing endo usa recalls

11 active

Reported	Class	Recall	Company	Reason	Where
20 May 2026Drug	CLASS II	Buprenorphine Hydrochloride, Injection, 3mg/mL, mL Single Dose Vials recalledBuprenorphine Hydrochloride	Endo Usa	Other	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 10 mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5 mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide

All endo usa recalls, newest first

11 total

Reported	Class	Recall	Company	Reason	Where
20 May 2026Drug	CLASS II	Buprenorphine Hydrochloride, Injection, 3mg/mL, mL Single Dose Vials recalledBuprenorphine Hydrochloride	Endo Usa	Other	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 10 mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5 mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
5 Nov 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
22 Oct 2025Drug	CLASS III	Everolimus tablets 5mg (each carton contains 4 blister recalled	Endo USA	Potency & Assay	Nationwide
12 Feb 2025Drug	CLASS I	Adrenalin Chloride Solution (Epinephrine Nasal Solution recalled	Endo Usa	Packaging Defects	Nationwide
15 Jan 2025Drug	CLASS I	Clonazepam Orally Disintegrating Tablets, USP, 25 mg, C-IV recalledClonazepam	Endo USA	Labeling Errors	Nationwide
15 Jan 2025Drug	CLASS I	Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV recalledClonazepam	Endo USA	Labeling Errors	Nationwide
15 Jan 2025Drug	CLASS I	Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV recalledClonazepam	Endo USA	Labeling Errors	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.